Guilhian Leipnitz

Dr. Guilhian Leipnitz

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in Neurochemistry International
Verified
Journal Article
Closed access
GLGuilhian Leipnitz
Guilhian Leipnitz
CSCristiana Schumacher
Cristiana Schumacher
KDKarina B. Dalcin
Karina B. Dalcin
KSKarina Scussiato
Karina Scussiato
ASAlexandre Solano
Alexandre Solano
MWMoacir Wajner
Moacir Wajner

1 April 2010 in Brain Research
Verified
Journal Article
Closed access
AAAlexandre Umpierrez Amaral
Alexandre Umpierrez Amaral
GLGuilhian Leipnitz
Guilhian Leipnitz
CFCarolina Gonçalves Fernandes
Carolina Gonçalves Fernandes
BSBianca Seminotti
Bianca Seminotti
PSPatrícia Fernanda Schuck
Patrícia Fernanda Schuck
MWMoacir Wajner
Moacir Wajner

1 January 2002 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
CSCleide G da Silva
Cleide G da Silva
CRCesar Ribeiro
Cesar Ribeiro
GLGuilhian Leipnitz
Guilhian Leipnitz
CDCarlos S Dutra-Filho
Carlos S Dutra-Filho
AWAngela Wyse
Angela Wyse
MWMoacir Wajner
Moacir Wajner

1 August 2013 in Neuroscience
Verified
Journal Article
Closed access
TMT.B. Marcelino
T.B. Marcelino
ALA. Longoni
A. Longoni
KKK.Y. Kudo
K.Y. Kudo
VSV. Stone
V. Stone
ARA. Rech
A. Rech
CMC. Matté
C. Matté

23 September 2009 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CFCarolina G. Fernandes
Carolina G. Fernandes
GLGuilhian Leipnitz
Guilhian Leipnitz
BSBianca Seminotti
Bianca Seminotti
AAAlexandre U. Amaral
Alexandre U. Amaral
ÂZÂngela Zanatta
Ângela Zanatta
MWMoacir Wajner
Moacir Wajner

18 January 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
GLGuilhian Leipnitz
Guilhian Leipnitz
AMAl-Walid Mohsen
Al-Walid Mohsen
AKAnuradha Karunanidhi
Anuradha Karunanidhi
BSBianca Seminotti
Bianca Seminotti
VRVera Y. Roginskaya
Vera Y. Roginskaya
JVJerry Vockley
Jerry Vockley
Mitochondrial complex I (CI) deficiency is the most frequent cause of oxidative phosphorylation (OXPHOS) disorders in humans. In order to benchmark the effects of CI deficiency on mitochondrial bioenergetics and dynamics, respiratory chain (RC) and endoplasmic reticulum (ER)-mitochondria communication, and superoxide production, fibroblasts from patients with mutations in the ND6, NDUFV1 or ACAD9 genes were analyzed. Fatty acid metabolism, basal and maximal respiration, mitochondrial membrane potential, and ATP levels were decreased. Changes in proteins involved in mitochondrial dynamics were detected in various combinations in each cell line, while variable changes in RC components were observed. ACAD9 deficient cells exhibited an increase in RC complex subunits and DDIT3, an ER stress marker. The level of proteins involved in ER-mitochondria communication was decreased in ND6 and ACAD9 deficient cells. |ΔΨ| and cell viability were further decreased in all cell lines. These findings suggest that disruption of mitochondrial bioenergetics and dynamics, ER-mitochondria crosstalk, and increased superoxide contribute to the pathophysiology in patients with ACAD9 deficiency. Furthermore, treatment of ACAD9 deficient cells with JP4-039, a novel mitochondria-targeted reactive oxygen species, electron and radical scavenger, decreased superoxide level and increased basal and maximal respiratory rate, identifying a potential therapeutic intervention opportunity in CI deficiency.